Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin A

Journal of Biomolecular Screening

Volumn 18, Issue 7, 2013, Pages 837-844

  Cash, Jennifer N ^a   Angerman, Elizabeth B ^a   Kirby, R Jason ^b   Merck, Lisa ^b   Seibel, William L ^b   Wortman, Matthew D ^b   Papoian, Ruben ^b   Nelson, Sandra ^b   Thompson, Thomas B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

cell based assays; musculoskeletal diseases; pharmacology: ligand binding; receptor binding; reporter gene assays; signal transduction

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; ACTIVIN A INHIBITOR; CYTOKINE RECEPTOR ANTAGONIST; LUCIFERASE; MYOSTATIN; MYOSTATIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; COMPUTER MODEL; CONTROLLED STUDY; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; PEPTIDE LIBRARY; PRIORITY JOURNAL; REPORTER GENE; SMALL MOLECULE SCREENING METHOD;

EID: 84880832583     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057113482585     Document Type: Article

References (15)

1. Shi Y., Massague J.. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus. Cell. 2003 ; 113: 685-700
2. Rider C. C., Mulloy B.. Bone Morphogenetic Protein and Growth Differentiation Factor Cytokine Families and Their Protein Antagonists. Biochem. J. 2010 ; 429: 1-12
3. Lee S. J., McPherron A. C.. Regulation of Myostatin Activity and Muscle Growth. Proc. Natl. Acad. Sci. U. S. A.. 2001 ; 98: 9306-9311
4. Inman G. J., Nicolas F. J., Callahan J. F., Harling J. D., Gaster L. M., Reith A. D., Laping N. J., Hill C. S.. SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-beta Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 2002 ; 62: 65-74
5. Guckian K., Carter M. B., Lin E. Y., Choi M., Sun L., Boriack-Sjodin P. A., Chuaqui C., Lane B., Cheung K., Ling L., et al. Pyrazolone Based TGFbetaR1 Kinase Inhibitors. Bioorg. Med. Chem. Lett. 2010 ; 20: 326-329
6. Yingling J. M., Blanchard K. L., Sawyer J. S.. Development of TGF-beta Signalling Inhibitors for Cancer Therapy. Nat. Rev. Drug Discov. 2004 ; 3: 1011-1022
7. Cadena S. M., Tomkinson K. N., Monnell T. E., Spaits M. S., Kumar R., Underwood K. W., Pearsall R. S., Lachey J. L.. Administration of a Soluble Activin Type IIB Receptor Promotes Skeletal Muscle Growth Independent of Fiber Type. J. Appl. Physiol. 2010 ; 109: 635-642
8. Kota J., Handy C. R., Haidet A. M., Montgomery C. L., Eagle A., Rodino-Klapac L. R., Tucker D., Shilling C. J., Therlfall W. R., Walker C. M., et al. Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates. Sci. Transl. Med. 2009 ; 1: 6ra15
9. Cash J. N., Rejon C. A., McPherron A. C., Bernard D. J., Thompson T. B.. The Structure of Myostatin:Follistatin 288: Insights into Receptor Utilization and Heparin Binding. Embo. J. 2009 ; 28: 2662-2676
10. Korupolu R. V., Muenster U., Read J. D., Vale W., Fischer W. H.. Activin A/Bone Morphogenetic Protein (BMP) Chimeras Exhibit BMP-Like Activity and Antagonize Activin and Myostatin. J. Biol. Chem. 2008 ; 283: 3782-3790
11. Cash J. N., Angerman E. B., Kattamuri C., Nolan K., Zhao H., Sidis Y., Keutmann H. T., Thompson T. B.. The Structure of Myostatin:Follistatin-Like 3: N-terminal Domains of Follistatin-Type Molecules Exhibit Alternate Modes of Binding. J. Biol. Chem. 2012 ; 287: 1043-1053
12. McGaughey G. B., Sheridan R. P., Bayly C. I., Culberson J. C., Kreatsoulas C., Lindsley S., Maiorov V., Truchon J. F., Cornell W. D.. Comparison of Topological, Shape, and Docking Methods in Virtual Screening. J. Chem. Inf. Model. 2007 ; 47: 1504-1519
13. Sukuru S. C., Jenkins J. L., Beckwith R. E., Scheiber J., Bender A., Mikhailov D., Davies J. W., Glick M.. Plate-Based Diversity Selection Based on Empirical HTS Data to Enhance the Number of Hits and Their Chemical Diversity. J. Biomol. Screen. 2009 ; 14: 690-699
14. Zhang J. H., Chung T. D., Oldenburg K. R.. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999 ; 4: 67-73
15. Tsuchida K., Sunada Y., Noji S., Murakami T., Uezumi A., Nakatani M.. Inhibitors of the TGF-beta Superfamily and Their Clinical Applications. Mini Rev. Med. Chem. 2006 ; 6: 1255-1261